Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

Related Citations for PubMed (Select 21788392)

1.

A high-throughput screening assay for the identification of flavivirus NS5 capping enzyme GTP-binding inhibitors: implications for antiviral drug development.

Geiss BJ, Stahla-Beek HJ, Hannah AM, Gari HH, Henderson BR, Saeedi BJ, Keenan SM.

J Biomol Screen. 2011 Sep;16(8):852-61. doi: 10.1177/1087057111412183. Epub 2011 Jul 25.

2.

Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme.

Stahla-Beek HJ, April DG, Saeedi BJ, Hannah AM, Keenan SM, Geiss BJ.

J Virol. 2012 Aug;86(16):8730-9. doi: 10.1128/JVI.00384-12. Epub 2012 Jun 6.

3.

Recognition of RNA cap in the Wesselsbron virus NS5 methyltransferase domain: implications for RNA-capping mechanisms in Flavivirus.

Bollati M, Milani M, Mastrangelo E, Ricagno S, Tedeschi G, Nonnis S, Decroly E, Selisko B, de Lamballerie X, Coutard B, Canard B, Bolognesi M.

J Mol Biol. 2009 Jan 9;385(1):140-52. doi: 10.1016/j.jmb.2008.10.028. Epub 2008 Oct 19.

PMID:
18976670
4.

Analysis of RNA binding by the dengue virus NS5 RNA capping enzyme.

Henderson BR, Saeedi BJ, Campagnola G, Geiss BJ.

PLoS One. 2011;6(10):e25795. doi: 10.1371/journal.pone.0025795. Epub 2011 Oct 12.

5.

Analysis of flavivirus NS5 methyltransferase cap binding.

Geiss BJ, Thompson AA, Andrews AJ, Sons RL, Gari HH, Keenan SM, Peersen OB.

J Mol Biol. 2009 Feb 6;385(5):1643-54. doi: 10.1016/j.jmb.2008.11.058. Epub 2008 Dec 11.

6.

Structure of the methyltransferase domain from the Modoc virus, a flavivirus with no known vector.

Jansson AM, Jakobsson E, Johansson P, Lantez V, Coutard B, de Lamballerie X, Unge T, Jones TA.

Acta Crystallogr D Biol Crystallogr. 2009 Aug;65(Pt 8):796-803. doi: 10.1107/S0907444909017260. Epub 2009 Jul 10.

PMID:
19622863
7.

Structure and functionality in flavivirus NS-proteins: perspectives for drug design.

Bollati M, Alvarez K, Assenberg R, Baronti C, Canard B, Cook S, Coutard B, Decroly E, de Lamballerie X, Gould EA, Grard G, Grimes JM, Hilgenfeld R, Jansson AM, Malet H, Mancini EJ, Mastrangelo E, Mattevi A, Milani M, Moureau G, Neyts J, Owens RJ, Ren J, Selisko B, Speroni S, Steuber H, Stuart DI, Unge T, Bolognesi M.

Antiviral Res. 2010 Aug;87(2):125-48. doi: 10.1016/j.antiviral.2009.11.009. Epub 2009 Nov 27. Review.

8.

Flaviviral methyltransferase/RNA interaction: structural basis for enzyme inhibition.

Milani M, Mastrangelo E, Bollati M, Selisko B, Decroly E, Bouvet M, Canard B, Bolognesi M.

Antiviral Res. 2009 Jul;83(1):28-34. doi: 10.1016/j.antiviral.2009.03.001. Epub 2009 Mar 14.

PMID:
19501254
9.

Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus.

Lim SV, Rahman MB, Tejo BA.

BMC Bioinformatics. 2011;12 Suppl 13:S24. doi: 10.1186/1471-2105-12-S13-S24. Epub 2011 Nov 30.

10.

Flavivirus methyltransferase: a novel antiviral target.

Dong H, Zhang B, Shi PY.

Antiviral Res. 2008 Oct;80(1):1-10. doi: 10.1016/j.antiviral.2008.05.003. Epub 2008 Jun 5. Review.

11.

The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure.

Issur M, Geiss BJ, Bougie I, Picard-Jean F, Despins S, Mayette J, Hobdey SE, Bisaillon M.

RNA. 2009 Dec;15(12):2340-50. doi: 10.1261/rna.1609709. Epub 2009 Oct 22.

12.

Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.

Lescar J, Luo D, Xu T, Sampath A, Lim SP, Canard B, Vasudevan SG.

Antiviral Res. 2008 Nov;80(2):94-101. doi: 10.1016/j.antiviral.2008.07.001. Epub 2008 Jul 30. Review.

PMID:
18674567
13.
14.

Development of specific dengue virus 2'-O- and N7-methyltransferase assays for antiviral drug screening.

Barral K, Sallamand C, Petzold C, Coutard B, Collet A, Thillier Y, Zimmermann J, Vasseur JJ, Canard B, Rohayem J, Debart F, Decroly E.

Antiviral Res. 2013 Sep;99(3):292-300. doi: 10.1016/j.antiviral.2013.06.001. Epub 2013 Jun 12.

PMID:
23769894
15.

Chapter 2. New insights into flavivirus nonstructural protein 5.

Davidson AD.

Adv Virus Res. 2009;74:41-101. doi: 10.1016/S0065-3527(09)74002-3. Review.

PMID:
19698895
16.

Flavivirus NS3 and NS5 proteins interaction network: a high-throughput yeast two-hybrid screen.

Le Breton M, Meyniel-Schicklin L, Deloire A, Coutard B, Canard B, de Lamballerie X, Andre P, Rabourdin-Combe C, Lotteau V, Davoust N.

BMC Microbiol. 2011 Oct 20;11:234. doi: 10.1186/1471-2180-11-234.

17.

Structural and functional analysis of methylation and 5'-RNA sequence requirements of short capped RNAs by the methyltransferase domain of dengue virus NS5.

Egloff MP, Decroly E, Malet H, Selisko B, Benarroch D, Ferron F, Canard B.

J Mol Biol. 2007 Sep 21;372(3):723-36. Epub 2007 Jul 12.

PMID:
17686489
18.

Focus on flaviviruses: current and future drug targets.

Geiss BJ, Stahla H, Hannah AM, Gari AM, Keenan SM.

Future Med Chem. 2009 May;1(2):327-44. doi: 10.4155/fmc.09.27. Review.

19.

Structure and function of flavivirus NS5 methyltransferase.

Zhou Y, Ray D, Zhao Y, Dong H, Ren S, Li Z, Guo Y, Bernard KA, Shi PY, Li H.

J Virol. 2007 Apr;81(8):3891-903. Epub 2007 Jan 31.

20.

Detection and quantification of flavivirus NS5 methyl-transferase activities.

Lim SP, Bodenreider C, Shi PY.

Methods Mol Biol. 2013;1030:249-68. doi: 10.1007/978-1-62703-484-5_20.

PMID:
23821274
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk